Is MEDS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MEDS. It does not provide personalized investment advice.

MEDS (DataMeds AI, Inc. Common Stock) Stock Analysis - Financials

DataMeds AI, Inc. Common Stock (MEDS) is a publicly traded the market company. As of July 29, 2026, MEDS trades at $3.37 with a market cap of $7.84M and a P/E ratio of -0.16. MEDS moved -4.37% today. Year to date, MEDS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.86 to $3.88. Rallies surfaces MEDS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MEDS's key financials?

MEDS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MEDS recently traded at $3.37. Market cap is $7.84M. P/E ratio is -0.16. Revenue is $8.27M.

MEDS Key Metrics

Key financial metrics for MEDS
Metric	Value
Price	$3.37
Market Cap	$7.84M
P/E Ratio	-0.16
EPS	$-23.35
Dividend Yield	1.50%
52-Week High	$3.88
52-Week Low	$2.86
Volume	44.68K
Avg Volume	0
Revenue (TTM)	$8.27M
Net Income	$-17.84M
Gross Margin	31.41%

MEDS Analyst Consensus

MEDS analyst coverage data. Average price target: $0.00.

Common questions about MEDS

What are MEDS's key financials?: MEDS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MEDS recently traded at $3.37. Market cap is $7.84M. P/E ratio is -0.16. Revenue is $8.27M.
Is MEDS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MEDS. It does not provide personalized investment advice.